Lanreotide Acetate Production Cost Reports

The report provides a detailed analysis essential for establishing a Lanreotide Acetate production plant. It encompasses all critical aspects necessary for Lanreotide Acetate production, including the cost of Lanreotide Acetate production, Lanreotide Acetate plant cost, Lanreotide Acetate production costs, and the overall Lanreotide Acetate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Lanreotide Acetate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Lanreotide Acetate is a synthetic drug that finds its major applications in the medical and pharmaceutical industries. The drug is widely utilized for the treatment of acromegaly, a hormonal disorder, and in the management of symptoms caused by neuroendocrine tumors. Moreover, it is also used as a medication for the treatment of gastrointestinal fistulae, pituitary neoplasms, and metastases to peritoneum. Additionally, the drug also finds its applications in the formulation of lanreotide injection for the long-term treatment of acromegaly in patients who cannot undergo surgical procedures.

The market for lanreotide acetate is driven by its usage as a medication to treat acromegaly, Gastroenteropancreatic neuroendocrine tumors, and Carcinoid syndrome in adults, which significantly contributes to its demand in the medical industry. Additionally, its application of a prolonged-release microparticle for the long-term treatment of acromegaly in some specific patients by reducing the amount of growth hormones further enhances its demand in the medical and pharmaceutical industries. Furthermore, several factors influence industrial Lanreotide Acetate procurement, such as the availability of raw materials (tetrapeptides, etc.), cost and pricing, compliance with medical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.

Raw Material for Lanreotide Acetate

According to the Lanreotide Acetate production plant project report, the major raw materials for Lanreotide Acetate production include Tetrapeptides-Acetic Acid.

Production Process of Lanreotide Acetate

The extensive Lanreotide Acetate production cost report consists of the following industrial production process:

• Production via Coupling Reaction: This method of production involves multiple steps for the production of Lanreotide acetate as the final product. The process is initiated by the preparation of two smaller peptide segments. Each of them contains four amino acids, called tetrapeptides, followed by protecting these segments with certain chemical groups, specifically the hydroxyl group of threonine, to prevent them from reacting unnecessarily. Further, these protected tetrapeptides are coupled together to form an octapeptide, followed by its deprotection (removal of the protecting groups) to expose the reactive sites. After deprotection, octapeptide undergoes oxidation, followed by treatment with acetic acid, which results in the formation of Lanreotide acetate.

Lanreotide Acetate is the acetate salt of a cyclic octapeptide similar to somatostatin. The molecular formula of the compound is C56H73N11O12S2, and its molar mass is 1156.4 g/mol. Moreover, the IUPAC name of the compound is also known as Angiopeptin acetate or Somatuline. This drug is available in the form of a deep subcutaneous injection. Additionally, the drug finds huge applications in the medical and pharmaceutical industries for the treatment of acromegaly. This drug is generally marketed under the brand name Somatuline.